• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关成纤维细胞通过调节肺癌细胞中的 ANXA3 促进顺铂耐药性。

Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.

机构信息

Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.

Department of Pathology, Tianjin Chest Hospital, Tianjin, China.

出版信息

Cancer Sci. 2019 May;110(5):1609-1620. doi: 10.1111/cas.13998. Epub 2019 Apr 9.

DOI:10.1111/cas.13998
PMID:30868675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6500998/
Abstract

Cancer tissues consist of cancer cells, surrounding stromal cells and the extracellular matrix. Cancer-associated fibroblasts (CAF) are one of the key components of stromal cells. CAF have a great impact on the behavior of cancer cells, including proliferation, invasion, metastasis and chemoresistance in many ways. However, the underlying mechanism had not been fully elucidated. In this study, we investigated the role of CAF in cisplatin resistance of lung cancer cells. By using conditioned medium from CAF (CAF-CM), we found that CAF decreased the sensitivity of lung cancer cells to cisplatin. RNA sequencing results showed that CAF expressed a higher level of Annexin A3 (ANXA3) than normal fibroblasts (NF), and CAF-CM incubation increased the ANXA3 level in lung cancer cells. Overexpression of ANXA3 in lung cancer cells increased cisplatin resistance and activated c-jun N-terminal kinase (JNK), whereas knockdown of ANXA3 increased cisplatin sensitivity. Further study showed that CAF-CM enhanced cisplatin resistance by inhibiting cisplatin-induced apoptosis, determined by repression of caspase-3 and caspase-8, through activation of the ANXA3/JNK pathway. Conversely, suppression of JNK activation by specific inhibitor retarded the effect of CAF-CM and ANXA3 on cisplatin sensitivity. Taken together, our study demonstrated that CAF potentiated chemoresistance of lung cancer cells through a novel ANXA3/JNK pathway both in vitro and in vivo, suggesting ANXA3 could be a potential therapeutic target for the treatment of chemoresistant cancer.

摘要

肿瘤组织由癌细胞、周围的基质细胞和细胞外基质组成。癌症相关成纤维细胞(CAF)是基质细胞的关键组成部分之一。CAF 以多种方式对癌细胞的行为产生重大影响,包括增殖、侵袭、转移和化疗耐药性。然而,其潜在机制尚未完全阐明。在这项研究中,我们研究了 CAF 在肺癌细胞顺铂耐药中的作用。通过使用 CAF 的条件培养基(CAF-CM),我们发现 CAF 降低了肺癌细胞对顺铂的敏感性。RNA 测序结果表明,CAF 表达的 Annexin A3(ANXA3)水平高于正常成纤维细胞(NF),并且 CAF-CM 孵育增加了肺癌细胞中的 ANXA3 水平。肺癌细胞中 ANXA3 的过表达增加了顺铂耐药性,并激活了 c-jun N 末端激酶(JNK),而 ANXA3 的敲低则增加了顺铂敏感性。进一步的研究表明,CAF-CM 通过抑制 caspase-3 和 caspase-8 的表达,通过激活 ANXA3/JNK 通路,抑制顺铂诱导的细胞凋亡,从而增强肺癌细胞的顺铂耐药性。相反,通过特异性抑制剂抑制 JNK 激活会延迟 CAF-CM 和 ANXA3 对顺铂敏感性的影响。总之,我们的研究表明,CAF 通过一种新型的 ANXA3/JNK 通路在体外和体内增强了肺癌细胞的化疗耐药性,提示 ANXA3 可能成为治疗化疗耐药性癌症的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/c2c0177fb1a9/CAS-110-1609-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/6a8b94c81035/CAS-110-1609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/600956e1e50f/CAS-110-1609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/d153760275cd/CAS-110-1609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/71a3ccd21d7f/CAS-110-1609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/d99581315e98/CAS-110-1609-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/381c0b998e29/CAS-110-1609-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/fd77fada9ad9/CAS-110-1609-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/ff12caa0f5f9/CAS-110-1609-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/c2c0177fb1a9/CAS-110-1609-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/6a8b94c81035/CAS-110-1609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/600956e1e50f/CAS-110-1609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/d153760275cd/CAS-110-1609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/71a3ccd21d7f/CAS-110-1609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/d99581315e98/CAS-110-1609-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/381c0b998e29/CAS-110-1609-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/fd77fada9ad9/CAS-110-1609-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/ff12caa0f5f9/CAS-110-1609-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bba/6500998/c2c0177fb1a9/CAS-110-1609-g009.jpg

相似文献

1
Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.癌症相关成纤维细胞通过调节肺癌细胞中的 ANXA3 促进顺铂耐药性。
Cancer Sci. 2019 May;110(5):1609-1620. doi: 10.1111/cas.13998. Epub 2019 Apr 9.
2
ANXA3 deletion inhibits the resistance of lung cancer cells to oxaliplatin.膜联蛋白 A3 缺失抑制肺癌细胞对奥沙利铂的耐药性。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3741-3748. doi: 10.26355/eurrev_202004_20838.
3
Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.膜联蛋白 A3 耗竭通过 MAPK 信号通路克服结直肠癌对奥沙利铂的耐药性。
J Cell Biochem. 2019 Sep;120(9):14585-14593. doi: 10.1002/jcb.28720. Epub 2019 Apr 18.
4
Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.膜联蛋白A3促进肝细胞癌的肿瘤发生及化疗耐药。
Mol Carcinog. 2015 Aug;54(8):598-607. doi: 10.1002/mc.22126. Epub 2013 Dec 23.
5
Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.膜联蛋白 A3 敲低抑制肺腺癌。
Anal Cell Pathol (Amst). 2016;2016:4131403. doi: 10.1155/2016/4131403. Epub 2016 Nov 22.
6
Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.下调膜联蛋白 A3 抑制乳腺癌转移并降低耐药性。
Cell Death Dis. 2018 Jan 26;9(2):126. doi: 10.1038/s41419-017-0143-z.
7
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.顺铂处理的癌相关成纤维细胞通过 IL-11/IL-11R/STAT3 信号通路促进肺腺癌的化疗耐药性。
Sci Rep. 2016 Dec 6;6:38408. doi: 10.1038/srep38408.
8
33-kDa ANXA3 isoform contributes to hepatocarcinogenesis modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways.33-kDa 膜联蛋白 A3 同工型促进肝癌发生,调控 ERK、PI3K/Akt-HIF 和内在凋亡途径。
J Adv Res. 2020 Nov 8;30:85-102. doi: 10.1016/j.jare.2020.11.003. eCollection 2021 May.
9
Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma miR-876-3p.肿瘤相关成纤维细胞衍生的细胞外囊泡对口腔鳞状细胞癌细胞顺铂耐药性的差异影响 miR-876-3p。
Theranostics. 2024 Jan 1;14(2):460-479. doi: 10.7150/thno.87329. eCollection 2024.
10
[Cancer-associated-fibroblasts regulate the chemoresistance of lung cancer cell line A549 via SDF-1 secretion].[癌症相关成纤维细胞通过分泌基质细胞衍生因子-1调节肺癌细胞系A549的化疗耐药性]
Zhonghua Zhong Liu Za Zhi. 2017 May 23;39(5):339-343. doi: 10.3760/cma.j.issn.0253-3766.2017.05.004.

引用本文的文献

1
ERCC6L-mediated stabilization of HIF-1α enhances glycolysis and stemness properties of lung adenocarcinoma cells.ERCC6L介导的HIF-1α稳定增强了肺腺癌细胞的糖酵解和干性特性。
Cell Death Dis. 2025 Jul 21;16(1):541. doi: 10.1038/s41419-025-07879-4.
2
Cross-Talk Between Cancer and Its Cellular Environment-A Role in Cancer Progression.癌症与其细胞微环境之间的相互作用——在癌症进展中的作用
Cells. 2025 Mar 10;14(6):403. doi: 10.3390/cells14060403.
3
The FBXW7-KMT2 axis in cancer-associated fibroblasts controls tumor growth via an epigenetic-paracrine mechanism.

本文引用的文献

1
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens.在临床尿液样本中对膀胱癌相关组织蛋白生物标志物候选物进行系统验证。
Oncotarget. 2018 Jul 20;9(56):30731-30747. doi: 10.18632/oncotarget.24578.
2
A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.一种小分子激酶抑制剂CEP-1347可抑制存活素表达并使卵巢癌干细胞对紫杉醇敏感。
Anticancer Res. 2018 Aug;38(8):4535-4542. doi: 10.21873/anticanres.12757.
3
The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.
癌症相关成纤维细胞中的FBXW7-KMT2轴通过表观遗传旁分泌机制控制肿瘤生长。
Proc Natl Acad Sci U S A. 2025 Apr;122(13):e2423130122. doi: 10.1073/pnas.2423130122. Epub 2025 Mar 24.
4
FOXD1-activated ANXA3 facilitates cisplatin resistance of lung cancer cells via promoting ANXA4 expression.FOXD1激活的膜联蛋白A3通过促进膜联蛋白A4的表达促进肺癌细胞的顺铂耐药性。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 17. doi: 10.1007/s00210-025-04005-1.
5
Annexin A's Life in Pan-Cancer: Especially in Glioma Immune Cells.膜联蛋白A在泛癌中的作用:特别是在胶质瘤免疫细胞中的作用
Neuromolecular Med. 2025 Feb 26;27(1):17. doi: 10.1007/s12017-024-08827-9.
6
The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy.顺铂在调节肿瘤免疫微环境中的作用及其联合治疗策略:增强抗肿瘤疗效的新方法。
Ann Med. 2025 Dec;57(1):2447403. doi: 10.1080/07853890.2024.2447403. Epub 2025 Jan 6.
7
A review of current developments in RNA modifications in lung cancer.肺癌中RNA修饰的当前进展综述。
Cancer Cell Int. 2024 Oct 25;24(1):347. doi: 10.1186/s12935-024-03528-6.
8
3D cell culture models in research: applications to lung cancer pharmacology.研究中的3D细胞培养模型:在肺癌药理学中的应用
Front Pharmacol. 2024 Sep 23;15:1438067. doi: 10.3389/fphar.2024.1438067. eCollection 2024.
9
Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell Carcinoma.评估膜联蛋白家族作为预测肾透明细胞癌进展和预后的潜在生物标志物。
Evid Based Complement Alternat Med. 2022 Jun 8;2022:8748434. doi: 10.1155/2022/8748434. eCollection 2022.
10
Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.癌相关成纤维细胞分泌 FGF5 以抑制铁死亡从而降低鼻咽癌对顺铂的敏感性,其机制与 FGFR2 结合有关。
Cell Death Dis. 2024 Apr 18;15(4):279. doi: 10.1038/s41419-024-06671-0.
膜联蛋白A3(ANXA3)的表达及其与乳腺癌发生发展的关系。
J BUON. 2018 May-Jun;23(3):713-719.
4
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib.阻断膜联蛋白 A3 可增强索拉非尼和瑞戈非尼对肝细胞癌的敏感性。
J Hepatol. 2018 Oct;69(4):826-839. doi: 10.1016/j.jhep.2018.05.034. Epub 2018 Jun 7.
5
MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis.miR-26a-5p 通过调控 ITGβ8-JAK2/STAT3 轴促进人肺癌细胞的转移。
Biochem Biophys Res Commun. 2018 Jun 22;501(2):494-500. doi: 10.1016/j.bbrc.2018.05.020. Epub 2018 May 10.
6
Proteomic profiling of antibody-inducing immunogens in tumor tissue identifies PSMA1, LAP3, ANXA3, and maspin as colon cancer markers.肿瘤组织中诱导抗体的免疫原的蛋白质组分析确定PSMA1、LAP3、ANXA3和maspin为结肠癌标志物。
Oncotarget. 2017 Dec 22;9(3):3996-4019. doi: 10.18632/oncotarget.23583. eCollection 2018 Jan 9.
7
Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.Survivin 靶向 miR-542-3p 克服 HER3 信号诱导的化疗耐药性,并增强紫杉醇对 HER2 过表达乳腺癌的抗肿瘤活性。
Cancer Lett. 2018 Apr 28;420:97-108. doi: 10.1016/j.canlet.2018.01.065. Epub 2018 Jan 31.
8
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer.药物抑制NOS 激活 ASK1/JNK 通路增强多西紫杉醇介导的三阴性乳腺癌细胞凋亡。
Clin Cancer Res. 2018 Mar 1;24(5):1152-1162. doi: 10.1158/1078-0432.CCR-17-1437. Epub 2018 Jan 4.
9
Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.苯乙基异硫氰酸酯通过 JAK2/STAT3 通路抑制自噬增强肺癌细胞的抗转移作用。
Mol Carcinog. 2018 Apr;57(4):522-535. doi: 10.1002/mc.22777. Epub 2018 Jan 17.
10
Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway.癌症相关成纤维细胞通过IL-6/STAT3信号通路增强肺癌细胞的转移潜能。
Oncotarget. 2017 Jun 28;8(44):76116-76128. doi: 10.18632/oncotarget.18814. eCollection 2017 Sep 29.